Stock RVU RYVU THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ryvu Therapeutics S.A.

Equities

RVU

PLSELVT00013

Delayed Warsaw S.E.
Other stock markets
 03:35:50 2024-04-29 EDT 		5-day change 1st Jan Change
49.3 PLN 0.00% Intraday chart for Ryvu Therapeutics S.A. -3.33% -14.26%
03-13 Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-06 Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting CI

Evolution of the average Target Price on Ryvu Therapeutics S.A.

Price target over the last 5 years

History of analyst recommendation changes

4c5.YsEzwqClsJlRj3BfjRnT-ym7GJFQYWUsQMJ10dg3Epk.V6pjpMff46AUwxEwxHCmqmTpXcI6Fkh1F_QChJ5eV60A9kSG6__frxroHw~4e12cd6cb6201bbc5a832dd796f12e1c

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
49.3 PLN
Average target price
73.12 PLN
Spread / Average Target
+48.33%
High Price Target
80 PLN
Spread / Highest target
+62.27%
Low Price Target
64 PLN
Spread / Lowest Target
+29.82%

Consensus detail

Consensus revision (last 18 months)

Ratings for Ryvu Therapeutics S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RVU Stock
  4. Consensus Ryvu Therapeutics S.A.